Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pseudoreceptor modeling - a tool in the pharmacological screening process]

Angelo Vedani1

  • 1Schweizerisches Institut für Alternativen zu Tierversuchen (SIAT), Biografik Labor, CH-Basel.

ALTEX
|January 1, 1994
PubMed
Summary

Pseudoreceptor modeling reconstructs unknown bioregulator structures from ligand data. This computational approach aids in predicting drug molecule binding strength and reduces the need for animal testing in early drug discovery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Profiling withanolide A for therapeutic targets in neurodegenerative diseases.

Bioorganic & medicinal chemistry·2019
Same author

In Silico Prediction of the Toxic Potential of Lupeol.

Chemical research in toxicology·2017
Same author

Probing Small-Molecule Binding to the Liver-X Receptor: A Mixed-Model QSAR Study.

Molecular informatics·2016
Same author

VirtualToxLab: Exploring the Toxic Potential of Rejuvenating Substances Found in Traditional Medicines.

Methods in molecular biology (Clifton, N.J.)·2016
Same author

Molecular mechanisms of endocrine and metabolic disruption: An in silico study on antitrypanosomal natural products and some derivatives.

Toxicology letters·2016
Same author

OpenVirtualToxLab--a platform for generating and exchanging in silico toxicity data.

Toxicology letters·2014

Area of Science:

  • Computational chemistry
  • Drug discovery
  • Biochemistry

Background:

  • Computer-Aided Drug Design (CADD) traditionally requires known receptor structures.
  • Limited information on biological receptors often necessitates in vivo studies.
  • Existing CADD techniques have limitations in generating explicit receptor models.

Purpose of the Study:

  • Introduce Pseudoreceptor Modeling as a novel CADD approach.
  • Enable the reconstruction of unknown bioregulator 3D structures.
  • Facilitate qualitative prediction of novel drug molecule binding strength.

Main Methods:

  • Reconstruction of unknown bioregulator 3D structure using known ligand structures.
  • Generation of an explicit pseudoreceptor model.

Related Experiment Videos

  • Application of the model for predicting binding strength of new drug molecules.

    • Main Results:

    • Successfully generated explicit pseudoreceptor models for unknown bioregulators.
    • Demonstrated the capability to predict qualitative binding strength of novel drug candidates.
    • Established pseudoreceptor modeling as a viable ex vivo screening technique.

    Conclusions:

    • Pseudoreceptor modeling significantly extends CADD possibilities.
    • This technique offers a promising alternative to animal testing by enabling ex vivo screening.
    • It is particularly relevant when information about the true biological receptor is scarce.